A breakthrough in biologic implants
We’re transforming reconstructive surgery
We are developing cartilage-derived technology that eliminates patient harvesting and has the potential for therapeutic benefit throughout the body.

Today, implants for facial plastic and reconstructive surgery are deeply flawed

Cartilage grafts ARE REABSORBED

Requires harvesting surgery, with high risk of resorption.

Source: PubMed

CADAVER TISSUE WARPS

Inconsistent quality and up to 75% long-term resorption rate, with tendency to warp.

Source: OTOHNS

Synthetics are REJECTED

Highly prone to extrusion, migration and infection; rejected by US surgeons.

Source: PubMed

We’re making surgery
safer and less invasive

Our patented cartilage-based technology is leading the way.

Time savings of up to 50% and no donor site complications

Our patented porcine cartilage technology is stable and biocompatible

1.
Obtain porcine
cartilage

Porcine cartilage is an inexpensive and easily sourced by-product.

Obtain porcine cartilage
2.
Decellularization

We remove cell material and preserve the extracellular matrix (ECM) that gives cartilage its strength and unique characteristics.

Decellularization
3.
Stabilization

We crosslink the ECM  to make it enzyme-resistant and long-lasting while retaining its biomechanical characteristics.

Stabilization
4.
Sterilization

We sterilize the cartilage without degrading the sensitive glycoaminoglycans to ensure efficacy and prevent infection.

Sterilization
Where we’re going:

Rosivo's technology has potential reconstructive applications throughout the body